BRISBANE: Radformation, a leader in radiation oncology software, and Icon Group, a global provider of cancer care, have announced a strategic partnership to improve treatment planning and quality assurance workflows. The collaboration will leverage the expertise of both innovators to deliver groundbreaking solutions that simplify and enhance the delivery of personalised cancer treatment. Radformation’s software,…
Alderley Park, UK: Jazz Pharmaceuticals plc and Redx Pharma plc have signed a definitive agreement under which Jazz will acquire Redx’s KRAS (Kirsten rat sarcoma virus) inhibitor program. Jazz and Redx will collaborate to advance candidates through IND-enabling studies; Jazz will be responsible for all clinical development, regulatory, manufacturing and commercialization activities. “KRAS is a…
NEW YORK: Merck & Co. seeks to acquire Seagen in a reportedly $40 billion deal or more, the Wall Street Journal reported Thursday. While talks could fall apart, the companies are discussing a price near $200 per share and want to come to terms by Merck’s quarterly earnings call on July 28, according to the report. Seagen…